Why Moderna Stock Is Down 25% In Recent Weeks
- Tuesday, December 29, 2020, 7:12
- Market
- Add a comment
Moderna’s stock has declined by roughly 25% over the last two weeks. While news from the company has been largely positive, with its Covid-19 vaccine receiving emergency approval from the U.S. FDA and dosing starting in the U.S., the decline in the stock is likely largely technical. Vaccine stocks..
About the Author
admin123 has written 23410 stories on this site.
